Cohance Lifesciences Limited
COHANCE
Pozycja w akcjach
#6366
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Cena akcji
$5.05
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$1.93B
Zmiana (1 dzień)
-1.44%
Zmiana (1 rok)
-57.38%
Kraj
IN
Handel Cohance Lifesciences Limited (COHANCE)
Kategoria
Healthcare
EPS dla Cohance Lifesciences Limited (COHANCE)
EPS na dzień June 2025 TTM: $0.11
Według najnowszych raportów finansowych i ceny akcji firmy Cohance Lifesciences Limited, obecny EPS (TTM) wynosi $0.11. Na koniec roku 2024 firma miała EPS w wysokości $0.14, spadek w porównaniu do do EPS z roku 2023, który wynosił $0.20.
Historia EPS dla Cohance Lifesciences Limited od 2019 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| 2026 (TTM) | $0.11 | -9.42% |
| 2025 | $0.12 | -13.07% |
| 2024 | $0.14 | -28.03% |
| 2023 | $0.20 | -16.30% |
| 2022 | $0.23 | 20.83% |
| 2021 | $0.19 | 17.60% |
| 2020 | $0.17 | 167.48% |
| 2019 | $0.06 | 0.00% |
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 411.78% |
IN
|
